You are here

Capital Markets

Navigating the global capital markets

Major economic impacts, political events and technological developments are reshaping the global capital markets. International securities offerings and listings are complex and require innovative solutions in increasingly competitive markets for capital.

We provide the world's leading companies, institutional and strategic shareholders and investment banks with advice on transactions and policy, empowering them with confidence to manage capital and mitigate risk.

As our practice is balanced between issuer and underwriter mandates, our clients receive commercial, insightful advice from capital markets specialists with technical expertise and a complete understanding of both sides of transactions. Our lawyers advise on the full range of equity, equity-linked and debt capital markets transactions across jurisdictions globally. Working together with experts in competition, disputes, employment, finance, real estate and tax, they identify and solve all challenges that arise.

Transaction types include initial public offerings (IPOs), secondary fundraisings including rights issues, placings and open offers, investment grade bonds and Euro medium-term note (EMTN) programmes, regulatory capital, liability management, exchangeable and convertible bonds, Securities and Exchange Commission (SEC)-registered offerings, high-yield bonds, Sukuk, sovereign and quasi-sovereign issues and structured securitisations (see securitisation and structured finance) stand collateral debt obligations (CDOs).

Our full service offering encompasses a wide range of products and sectors including banks, energy, infrastructure and transport, mining, pharmaceuticals and healthcare, real estate and technology, media and communications.

Diverse knowledge and in-depth expertise

Related news and deals

24 August 2021

Herbert Smith Freehills advises sponsors on Acotec Scientific’s HK$1.529 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为先瑞达医疗15.29亿港元IPO提供法律服务

20 August 2021

Herbert Smith Freehills advises on Shanghai HeartCare Medical's HK$1.13 billion Hong Kong IPO 史密夫斐尔律师事务所为心玮医疗11.3亿港元IPO提供法律服务

13 July 2021

Herbert Smith Freehills advises sponsors on Brii Biosciences’ HK$2.483 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为腾盛博药24.83亿港元IPO提供法律服务

12 July 2021

Herbert Smith Freehills advises sole sponsor on UNQ Holdings’ HK$364 million Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人境外律师为优趣汇3.64亿港元IPO提供法律服务